KidneyCell https://validator.w3.org/feed/docs/rss2.html Related Articles Technology KidneyCell Announces Launch of New Bioelectric Stimulation Study to Attempt to Reverse Kidney Failure KidneyCell Announces Issuance U.S. Patent No. 10,646,644 May 12th, 2020 with 20 Years Patent Life for Bioelectric and Biologics Based Kidney Regeneration Team Executive Summary KidneyCell Files Patent for Precise Bioelectric Klotho Increase Up to 430% Sample Page KidneyCell Proposed Clinical Study Protocol for KidneyCell Leonhardt Ventures Announces Launch of Research Program Using Patent Pending Klotho Expressing Mesenchymal Stem Cells for Multiple Applications in Combination with Bioelectric Protein Expressions Contact us Leonhardt’s Launchpads Medtech Accelerator Expands into Pittsburgh Leonhardt’s Launchpads Accelerator Announces Demo Days and Showcases September in San Francisco and Palo Alto for Organ Regeneration and Recovery Focused Startups Leonhardt’s Launchpads Announces Filing of Patent for Bioelectric Stimulation Controlled Klotho Expression – Powerful anti-aging and Regeneration Promoting Protein KidneyCell Announces Launch of New Bioelectric Stimulation Study to Attempt to Reverse Kidney Failure Leonhardt’s Launchpads and Leonhardt Ventures Release 2020 Annual Report ahead of Annual Shareholder Meeting April 23rd, 2020 News Leonhardt’s Launchpads Announces Issuance of New U.S. Patent for Bioelectric Plus Biologics Platform for Organ Regeneration and Healing FAQ